Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Montefiore Medical Center
Montefiore Medical Center
Dragonfly Therapeutics
Centre Oscar Lambret
Centre Oscar Lambret
SN BioScience
Varian, a Siemens Healthineers Company
I-Mab Biopharma US Limited
Maastricht Radiation Oncology
Hospices Civils de Lyon
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Incyte Corporation
MacroGenics
Delfi Diagnostics Inc.
Incyte Corporation
Genentech, Inc.
Celldex Therapeutics
Hoffmann-La Roche
Thomas Jefferson University
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Labcorp Corporation of America Holdings, Inc
Intensity Therapeutics, Inc.
Inova Health Care Services
Cedars-Sinai Medical Center
Cyprus University of Technology
Medical University of South Carolina
BioAtla, Inc.
Cyteir Therapeutics, Inc.
BeiGene
Taproot Health
Jacobio Pharmaceuticals Co., Ltd.
Acepodia Biotech, Inc.
Washington University School of Medicine
Jacobio Pharmaceuticals Co., Ltd.
Xencor, Inc.
Cedars-Sinai Medical Center
Pfizer
Celldex Therapeutics
Buddhist Tzu Chi General Hospital
STCube, Inc.
Istituti Clinici Scientifici Maugeri SpA
Massachusetts General Hospital
University Hospital, Ghent
CytomX Therapeutics
Umeå University
Emory University
Klus Pharma Inc.